OA08630A - Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant. - Google Patents

Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.

Info

Publication number
OA08630A
OA08630A OA59158A OA59158A OA08630A OA 08630 A OA08630 A OA 08630A OA 59158 A OA59158 A OA 59158A OA 59158 A OA59158 A OA 59158A OA 08630 A OA08630 A OA 08630A
Authority
OA
OAPI
Prior art keywords
preparation
compositions containing
active against
immunizing compositions
fraction active
Prior art date
Application number
OA59158A
Other languages
English (en)
French (fr)
Inventor
Montreuil Jean
Spik Genevieve
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of OA08630A publication Critical patent/OA08630A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
OA59158A 1986-07-07 1987-07-07 Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant. OA08630A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609842A FR2601021B2 (fr) 1986-07-07 1986-07-07 Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant

Publications (1)

Publication Number Publication Date
OA08630A true OA08630A (fr) 1988-11-30

Family

ID=9337146

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59158A OA08630A (fr) 1986-07-07 1987-07-07 Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.

Country Status (10)

Country Link
US (1) US5021560A (de)
EP (1) EP0252829A1 (de)
JP (1) JPH01139533A (de)
KR (1) KR880001703A (de)
AU (1) AU7528087A (de)
DK (1) DK347987A (de)
FR (1) FR2601021B2 (de)
OA (1) OA08630A (de)
PT (1) PT85278B (de)
ZA (1) ZA874920B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
TR200202066T2 (tr) * 1999-03-12 2004-12-21 University Of Massachusetts Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
DE19939578A1 (de) 1999-08-20 2001-02-22 Biosyn Arzneimittel Gmbh Nukleinsäuremolekül, umfassend eine für ein Hämocyanin kodierende Nukleinsäuresequenz
ES2552598T3 (es) * 1999-03-17 2015-11-30 Biosyn Arzneimittel Gmbh Hemocianina y secuencia de ácido nucleico que codifica para la misma
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
KR101245004B1 (ko) * 2010-10-14 2013-03-19 원광대학교산학협력단 주혈흡충증 진단에 유용한 합성 주혈흡충 특이항원 및 이를 포함하는 주혈흡충증의 검출을 위한 진단 키트
KR20250015935A (ko) * 2023-07-18 2025-02-03 서울대학교산학협력단 주혈흡충 감염 진단용 조성물 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2644149C3 (de) * 1976-09-30 1979-04-12 Behringwerke Ag, 3550 Marburg Neue Parasiten-Antigene
US4384992A (en) * 1981-01-27 1983-05-24 Andre Capron Novel peptide from cultures of Schistosoma mansoni, a process for producing it and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
FR2601021A2 (fr) 1988-01-08
PT85278A (fr) 1987-08-01
KR880001703A (ko) 1988-04-26
ZA874920B (en) 1988-04-27
FR2601021B2 (fr) 1988-11-18
DK347987D0 (da) 1987-07-06
AU7528087A (en) 1988-12-08
JPH01139533A (ja) 1989-06-01
EP0252829A1 (de) 1988-01-13
US5021560A (en) 1991-06-04
PT85278B (pt) 1990-03-30
DK347987A (da) 1988-01-08

Similar Documents

Publication Publication Date Title
DE3784594D1 (de) Mikrokapseln enthaltende pharmazeutische zusammensetzungen.
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
FI874959L (fi) Tvaettmedelskomposition, som innehaoller etylendiamin-n,n'-dibaernstenssyra.
FI875209A7 (fi) Galeeninen valmiste.
FI863362L (fi) Farmaceutisk sammansaettning.
IT1225762B (it) Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI872733A7 (fi) Farmaseuttisia koostumuksia.
FI872554A7 (fi) Suukoostumuksia.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
FI872313A7 (fi) Farmaseuttisia ainekoostumuksia.
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
FI874414A7 (fi) Kontrolloidusti vapautuvia farmaseuttisiaainekokoomuksia.
DE3783937D1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
IT8619206A0 (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni.
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
IT1213536B (it) 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
IT8521622A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10triacetossi-1,8,9 antracene.
IT8619751A0 (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione.
IT8421627A0 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo.